Epiglottitis epidemiology and demographics: Difference between revisions
Prince Djan (talk | contribs) No edit summary |
Prince Djan (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==Epidemiology and demographics== | |||
===Incidence and prevalence=== | |||
With the advent of Haemophilus influenza tyoe b vaccine, the prevalence of epiglottitis has reduced for >90%.<ref name=Ter2015>{{cite book|last1=Des Jardins|first1=Terry|title=Clinical Manifestations & Assessment of Respiratory Disease|date=2015|publisher=Elsevier Health Sciences|isbn=9780323358972|page=529|edition=7|url=https://books.google.ca/books?id=PjQwBwAAQBAJ&pg=PA529}}</ref> | |||
In the United States it affects about 1.3 per 100,000 children a year. | |||
In adults between 1 and 4 per 100,000 are affected a year.<ref>{{cite book|title=Textbook of Adult Emergency Medicine|date=2014|publisher=Elsevier Health Sciences|isbn=9780702054389|page=291|edition=4|url=https://books.google.ca/books?id=gP1sAwAAQBAJ&pg=PA291|accessdate=15 July 2016}}</ref> | |||
===Gender=== | |||
===Age=== | |||
While historically young children were mostly affected, it is now more common among older children and adults. | |||
===Race=== | |||
===Developed vs developing countries=== | |||
It occurs more commonly in the [[developing world]].<ref>{{cite book|last1=Boons|first1=Geert-Jan|title=Carbohydrate-Based Vaccines and Immunotherapies.|date=2009|publisher=John Wiley & Sons|location=Hoboken|isbn=9780470473276|page=1222|url=https://books.google.ca/books?id=FfOzFBnZWlkC&pg=PA122}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 22:24, 9 January 2017
|
Epiglottitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Epiglottitis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Epiglottitis epidemiology and demographics |
|
Risk calculators and risk factors for Epiglottitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]
Overview
Epidemiology and demographics
Incidence and prevalence
With the advent of Haemophilus influenza tyoe b vaccine, the prevalence of epiglottitis has reduced for >90%.[1]
In the United States it affects about 1.3 per 100,000 children a year. In adults between 1 and 4 per 100,000 are affected a year.[2]
Gender
Age
While historically young children were mostly affected, it is now more common among older children and adults.
Race
Developed vs developing countries
It occurs more commonly in the developing world.[3]
References
- ↑ Des Jardins, Terry (2015). Clinical Manifestations & Assessment of Respiratory Disease (7 ed.). Elsevier Health Sciences. p. 529. ISBN 9780323358972.
- ↑ Textbook of Adult Emergency Medicine (4 ed.). Elsevier Health Sciences. 2014. p. 291. ISBN 9780702054389. Retrieved 15 July 2016.
- ↑ Boons, Geert-Jan (2009). Carbohydrate-Based Vaccines and Immunotherapies. Hoboken: John Wiley & Sons. p. 1222. ISBN 9780470473276.